PRECISION GRX Registry

Status:	Recruiting
Conditions:	Peripheral Vascular Disease, Cardiology
Therapuetic Areas:	Cardiology / Vascular Diseases
Healthy:	No
Age Range:	18 - Any
Updated:	3/7/2019
Start Date:	August 27, 2017
End Date:	August 31, 2019
Contact:	Tina Ridgeway, BS, RN
Email:	tina.ridgeway@corindus.com
Phone:	508-653-3335

A Multicenter Post-Market Registry for the Evaluation of the CorPath® GRX System Effectiveness in Percutaneous Coronary Interventions

To collect data on the routine patterns of use, safety and effectiveness, including the
clinical and technical performance of the CorPath GRX System, in the delivery and
manipulation of coronary guidewires and stent/balloon catheters, and manipulation of guide
catheters during PCI procedures.

This is a single-arm, open-label, multi-center patient registry of the CorPath GRX System to
examine its performance during PCI procedures and patient outcomes through 72 hours
post-procedure or hospital discharge, whichever occurs first.

Inclusion Criteria:

Candidates will be included in the study only if all of the following conditions are met:

1. Age ≥18 years;

2. Patients with coronary artery disease with clinical indication for PCI;

3. Patient deemed appropriate for robotic-assisted PCI; and

4. The subject has been informed of the nature of the study, agrees to its provisions and
has provided written informed consent.

Exclusion Criteria:

- Candidates will be excluded from the study if any of the following conditions are
present:

1. Failure/inability/unwillingness to provide informed consent; or

2. The investigator determines that the patient or the coronary anatomy is not
suitable for robotic-assisted PCI.

We found this trial at

sites

New York Presbyterian/Columbia University Medical Center

New York, New York 10065

Principal Investigator: Manish Parikh, MD

from

New York, NY